Figure 1: Impact Analysis of Market Drivers and Market Challenges on Global Single-Cell Multi-Omics Market
Figure 2: Global Single-Cell Multi-Omics Market (by Product Type), $Million, 2020 vs. 2025
Figure 3: Global Single-Cell Multi-Omics Market (by Application), $Million, 2020 vs. 2025
Figure 4: Global Single-Cell Multi-Omics Market (by Omics Type), $Million, 2020 vs. 2025
Figure 5: Global Single-Cell Multi-Omics Market (by Technique), $Million, 2020 vs. 2025
Figure 6: Global Single-Cell Multi-Omics Market (by Sample Type), $Million, 2020 vs. 2025
Figure 7: Global Single-Cell Multi-Omics Market (by End User), $Million, 2020 vs. 2025
Figure 8: Global Single-Cell Multi-Omics Market Snapshot
Figure 3.1: Primary Research Methodology
Figure 3.2: Bottom-Up Approach (Segment-Wise Analysis)
Figure 3.3: Top-Down Approach (Segment-Wise Analysis)
Figure 4.1: Single-Cell Multi-Omics Approach
Figure 4.2: Evolution of Single-Cell Multi-Omics Technology
Figure 4.4: Three Major Technological Developments in Single-Cell Sequencing
Figure 4.5: Traditional and Modern Approaches for Single-Cell Isolation
Figure 5.1: U.S. Prevalence of Lyme Disease 2009-2018
Figure 5.2: Global Prevalence Rate of Selected Rare Diseases Per 100,000 People
Figure 6.1: Market Share Analysis for the Global Single-Cell Multi-Omics Market, 2019
Figure 6.2: Growth Share Matrix for Global Single-Cell Multi-Omics Market (by Company), 2019
Figure 7.1: Global Single-Cell Multi-Omics Market (by Product Type)
Figure 7.2: Global Single-Cell Multi-Omics Market (Instruments), 2019-2025
Figure 7.3: Global Single-Cell Multi-Omics (Consumables), $Million, 2019-2025
Figure 7.4: Global Single-Cell Multi-Omics Market (Software), $Million, 2019-2025
Figure 8.1: Types of Omics Platforms
Figure 8.2: Global Single-Cell Genomics Market, $Million, 2019-2025
Figure 8.3: Global Single-Cell Transcriptomics Market, $Million, 2019-2025
Figure 8.4: Global Single-Cell Proteomics Market, $Million, 2019-2025
Figure 9.1: Global Single-Cell Multi-Omics Market (by Sample Type), $Million, 2019-2025
Figure 9.2: Global Single-Cell Multi-Omics Market (Human Samples), $Million, 2019-2025
Figure 9.3: Global Single-Cell Multi-Omics Market (Cancer Tissue), $Million, 2019-2025
Figure 9.4: Global Single-Cell Multi-Omics Market (Stem Cells), $Million, 2019-2025
Figure 9.5: Global Single-Cell Multi-Omics Market (Brain Cells), $Million, 2019-2025
Figure 9.6: Global Single-Cell Multi-Omics Market (Immune Cells), $Million, 2019-2025
Figure 9.7: Global Single-Cell Multi-Omics Market (Other Samples), $Million, 2019-2025
Figure 9.8: Global Single-Cell Multi-Omics Market (Animal Samples), $Million, 2019-2025
Figure 9.9: Global Single-Cell Multi-Omics Market (Microbial Samples), $Million, 2019-2025
Figure 10.1: Global Single-Cell Multi-Omics Market (by Technique)
Figure 10.2: Global Single-Cell Multi-Omics (Single-Cell Isolation and Dispensing), $Million, 2019-2025
Figure 10.3: Global Single-Cell Multi-Omics Market (FACS), $Million, 2019-2025
Figure 10.4: Global Single-Cell Multi-Omics Market (Manual Cell Picking), $Million, 2019-2025
Figure 10.5: Global Single-Cell Multi-Omics Market (MACS), $Million, 2019-2025
Figure 10.6: Global Single-Cell Multi-Omics Market (LCM), $Million, 2019-2025
Figure 10.7: Global Single-Cell Multi-Omics Market (Random Seeding), $Million, 2019-2025
Figure 10.8: Global Single-Cell Multi-Omics Market (Microfluidics), $Million, 2019-2025
Figure 10.9: Global Single-Cell Multi-Omics Market (Others), $Million, 2019-2025
Figure 10.10: Global Single-Cell Multi-Omics (Single-Cell Analysis), $Million, 2019-2025
Figure 10.11: Global Single-Cell Multi-Omics Market (Mass Cytometry), $Million, 2019-2025
Figure 10.12: Global Single-Cell Multi-Omics Market (Polymerase Chain Reaction), $Million, 2019-2025
Figure 10.13: Global Single-Cell Multi-Omics Market (Next-Generation Sequencing), $Million, 2019-2025
Figure 10.14: Global Single-Cell Multi-Omics Market (Mass Spectrometry), $Million, 2019-2025
Figure 10.15: Global Single-Cell Multi-Omics Market (Others), $Million, 2019-2025
Figure 11.1: Global Single-Cell Multi-Omics Market (Clinical Research), $Million, 2019-2025
Figure 11.2: Global Single-Cell Multi-Omics Market (Oncology), $Million, 2019-2025
Figure 11.3: Global Single-Cell Multi-Omics Market (Immunology), $Million, 2019-2025
Figure 11.4: Global Single-Cell Multi-Omics Market (by Neurology), $Million, 2019-2025
Figure 11.5: Global Single-Cell Multi-Omics Market (Cell Therapy), $Million, 2019-2025
Figure 11.6: Global Single-Cell Multi-Omics Market (Cell Biology), $Million, 2019-2025
Figure 11.7: Global Single-Cell Multi-Omics Market (Others), $Million, 2019-2025
Figure 11.8: Global Single-Cell Multi-Omics Market (Translational Research), $Million, 2019-2025
Figure 11.9: Global Single-Cell Multi-Omics Market (Synthetic Biology), $Million, 2019-2025
Figure 12.1: Global Single-Cell Multi-Omics Market (Research and Academia), $Million, 2019-2025
Figure 12.2: Global Single-Cell Multi-Omics Market (Contract Research Organizations), $Million, 2019-2025
Figure 12.3: Global Single-Cell Multi-Omics Market (Biopharmaceutical and Biotech Companies), $Million, 2019-2025
Figure 12.4: Global Single-Cell Multi-Omics Market (Other End Users), $Million, 2019-2025
Figure 13.1: Global Single-Cell Multi-Omics Market (by Region), $Million, 2020 and 2025
Figure 13.2: Global Single-Cell Multi-Omics Market (by Region), $Million, 2019-2025
Figure 13.3: North America Global Single-Cell Multi-Omics Market, $Million, 2019-2025
Figure 13.4: North America: Market Dynamics
Figure 13.5: North America Single-Cell Multi-Omics Market (by Country), $Million, 2019-2025
Figure 13.6: U.S. Single-Cell Multi-Omics Market, $Million, 2019-2025
Figure 13.7: Canada Single-Cell Multi-Omics Market, $Million, 2019-2025
Figure 13.8: Europe Single-Cell Multi-Omics Market, $Million, 2019-2025
Figure 13.9: Europe: Market Dynamics
Figure 13.10: Europe Global Single-Cell Multi-Omics Market (by Country), $Million, 2019-2025
Figure 13.11: Germany Single-Cell Multi-Omics Market, $Million, 2019-2025
Figure 13.12: France Single-Cell Multi-Omics Market, $Million, 2019-2025
Figure 13.13: U.K. Single-Cell Multi-Omics Market, $Million, 2019-2025
Figure 13.14: Italy Single-Cell Multi-Omics Market, $Millions, 2019-2025
Figure 13.15: Spain Single-Cell Multi-Omics Market, $Million, 2019-2025
Figure 13.16: Rest-of-Europe Single-Cell Multi-Omics Market, $Million, 2019-2025
Figure 13.17: Asia-Pacific Single-Cell Multi-Omics Market, $Million, 2019-2025
Figure 13.18: APAC: Market Dynamics
Figure 13.19: APAC Single-Cell Multi-Omics Market (by Country), $Million, 2019-2025
Figure 13.20: Japan Single-Cell Multi-Omics Market, $Million, 2019-2025
Figure 13.21: Singapore Single-Cell Multi-Omics Market, $Million, 2019-2025
Figure 13.22: India Single-Cell Multi-Omics Market, $Million, 2019-2025
Figure 13.23: China Single-Cell Multi-Omics Market, 2019-2025
Figure 13.24: Australia Single-Cell Multi-Omics Market, $Million, 2019-2025
Figure 13.25: RoAPAC Single-Cell Multi-Omics Market, $Million, 2019-2025
Figure 13.26: Latin America Single-Cell Multi-Omics Market, $Million, 2019-2025
Figure 13.27: Latin America: Market Dynamics
Figure 13.28: Latin America Single-Cell Multi-Omics Market (by Country), 2019-2025
Figure 13.29: Mexico Single-Cell Multi-Omics Market, $Million, 2019-2025
Figure 13.30: Brazil Single-Cell Multi-Omics Market, $Million, 2019-2025
Figure 13.31: Rest-of-Latin America Single-Cell Multi-Omics Market, $Million, 2019-2025
Figure 13.32: RoW Single-Cell Multi-Omics Market, $Million, 2019-2025
Figure 14.1: Total Number of Companies Profiled
Figure 14.2: 1CellBio, Inc.: Product Portfolio
Figure 14.3: 1CellBio: SWOT Analysis
Figure 14.4: Fluidigm Corporation: Product Portfolio
Figure 14.5: Fluidigm Corporation: Overall Financials, 2017-2019
Figure 14.6: Fluidigm Corporation: Revenue (by Business Segment), 2017-2019
Figure 14.7: Fluidigm Corporation.: Revenue (by Region), 2017-2019
Figure 14.8: Fluidigm Corporation: R&D Expenditure, 2017-2019
Figure 14.9: Fluidigm Corporation: SWOT Analysis
Figure 14.10: 10x Genomics, Inc.: Product Portfolio
Figure 14.11: 10x Genomics, Inc.: Overall Financials, 2017-2019
Figure 14.12: 10x Genomics, Inc.: Revenue (by Business Segment), 2017-2019
Figure 14.13: 10x Genomics, Inc.: Revenue (by Region), 2017-2019
Figure 14.14: 10x Genomics, Inc.: R&D Expenditure, 2017-2019
Figure 14.15: 10x Genomics, Inc.: SWOT Analysis
Figure 14.16: NanoString Technologies, Inc.: Product Portfolio
Figure 14.17: NanoString Technologies, Inc.: Overall Financials, 2017-2019
Figure 14.18: NanoString Technologies, Inc.: Revenue (by Business Segment), 2017-2019
Figure 14.19: NanoString Technologies, Inc.: Revenue (by Region), 2017-2019
Figure 14.20: NanoString Technologies, Inc.: R&D Expenditure, 2017-2019
Figure 14.21: NanoString Technologies, Inc.: SWOT Analysis
Figure 14.22: Bio-Techne Corporation: Product Portfolio
Figure 14.23: Bio-Techne Corporation: Overall Financials, 2020-2020
Figure 14.24: Bio-Techne Corporation: Revenue (by Business Segment), 2020-2020
Figure 14.25: Bio-Techne Corporation: Revenue (by Region), 2020-2020
Figure 14.26: Bio-Techne Corporation: R&D Expenditure, 2020-2020
Figure 14.27: Bio-Techne Corporation: SWOT Analysis
Figure 14.28: Bio-Rad Laboratories, Inc.: Product Portfolio
Figure 14.29: Bio-Rad Laboratories, Inc.: Overall Financials, 2017-2019
Figure 14.30: Bio-Rad Laboratories, Inc.: Revenue (by Segment), 2017-2019
Figure 14.31: Bio-Rad Laboratories, Inc.: Revenue (by Region), 2017-2019
Figure 14.32: Bio-Rad Laboratories, Inc.: R&D Expenditure, 2017-2019
Figure 14.33: Bio-Rad Laboratories, Inc.: SWOT Analysis
Figure 14.34: Mission Bio: Product Portfolio
Figure 14.35: Mission Bio: SWOT Analysis
Figure 14.36: Dolomite Bio: Product Portfolio
Figure 14.37: Dolomite Bio: SWOT Analysis
Figure 14.38: Fluxion Biosciences, Inc.: Product Portfolio
Figure 14.39: Fluxion Biosciences, Inc.: SWOT Analysis
Figure 14.40: Berkeley Lights, Inc.: Product Portfolio
Figure 14.41: Berkeley Lights, Inc.: Overall Financials, 2019-2020
Figure 14.42: Berkeley Lights, Inc.: Revenue (by Segment), 2018-2019
Figure 14.43: Berkeley Lights, Inc.: R&D Expenditure, 2017-2019
Figure 14.44: Berkeley Lights, Inc.: SWOT Analysis
Figure 14.45: RareCyte, Inc.: Overall Product Portfolio
Figure 14.46: RareCyte, Inc.: SWOT Analysis
Figure 14.47: Becton, Dickinson and Company: Product Portfolio
Figure 14.48: Becton, Dickinson and Company: Overall Financials, 2020-2020
Figure 14.49: Becton, Dickinson and Company: Revenue (by Business Segment), 2018-2020
Figure 14.50: Becton, Dickinson and Company: Revenue (by Region), 2018-2020
Figure 14.51: Becton, Dickinson and Company: R&D Expenditure, $Million, 2018-2020
Figure 14.52: Becton, Dickinson and Company: SWOT Analysis
Figure 14.53: Takara Bio, Inc.: Product Portfolio
Figure 14.54: Takara Bio Inc.: Overall Financials, (2018-2020)
Figure 14.55: Takara Bio, Inc.: Revenue (by Business Segment), 2018-2020
Figure 14.56: Takara Bio, Inc.: Revenue (by Region), 2019-2020
Figure 14.57: Takara Bio, Inc., R&D Expenditure, 2018-2020
Figure 14.58: Takara Bio Inc.: SWOT Analysis
Figure 14.59: Thermo Fisher Scientific, Inc.: Product Portfolio
Figure 14.60: Thermo Fisher Scientific Inc.: Overall Financials, 2017-2019
Figure 14.61: Thermo Fisher Scientific Inc.: Revenue (by Business Segment), 2017-2019
Figure 14.62: Thermo Fisher Scientific Inc.: Revenue (by Region), 2017-2019
Figure 14.63: Thermo Fisher Scientific Inc.: R&D Expenditure (2017-2019)
Figure 14.64: Thermo Fisher Scientific Inc.: SWOT Analysis
Figure 14.65: Namocell, Inc.: Product Portfolio
Figure 14.66: Namocell, Inc.: SWOT Analysis
Figure 15.1: Proteona: Product Portfolio
Figure 15.2: BioTuring, Inc.: Product Portfolio
Figure 15.3: Parse Biosciences, Inc.: Product Portfolio
Figure 15.4: Shilps Sciences: Product Portfolio